Novel Approach to Synthesis of Diaryl Tacrine Derivatives and Evaluation of Their Inhibitory Effects on Cholinesterase Enzymes

Fevzi Topal , Salih Ökten , Büşra Albayrak Misir , Ümit Muhammet Koçyiğit , Yavuz Derın , Vildan Enısoğlu Atalay , Ahmet Tutar , Meryem Topal

Chemical Research in Chinese Universities ›› 2026, Vol. 42 ›› Issue (3) : 983 -991.

PDF
Chemical Research in Chinese Universities ›› 2026, Vol. 42 ›› Issue (3) :983 -991. DOI: 10.1007/s40242-026-6048-6
Research Article
research-article
Novel Approach to Synthesis of Diaryl Tacrine Derivatives and Evaluation of Their Inhibitory Effects on Cholinesterase Enzymes
Author information +
History +
PDF

Abstract

The development of effective acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitors remains a crucial objective in the treatment of neurodegenerative diseases, including Alzheimer’s disease (AD). In this study, a novel synthetic approach was established to prepare a series of diaryl-substituted tacrine derivatives. Initially, brominated aminobenzonitrile was subjected to Suzuki-Miyaura cross-coupling reactions with various aryl boronic acids to yielding diaryl-substituted aminobenzonitriles at yields of 60%–72%. These intermediates were then cyclized with cyclohexanone and cycloheptanone under Friedländer conditions using BF3·OEt2 as a catalyst, affording six- and seven-membered diaryl tacrine analogues in yields of 52%–68%. All synthesized compounds were characterized by NMR, IR, and elemental analysis. The inhibitory activities of these compounds (7–16) against AChE and BChE were evaluated, and several analogs demonstrated potent dual-enzyme inhibition at nanomolar concentrations. Notably, compounds 8 and 13 exhibited half maximal inhibitory concentration (IC50) values of 6.848 and 8.545 nmol/L for BChE, respectively, indicating strong potential as selective cholinesterase inhibitors. The structure-activity relationship (SAR) analysis revealed the influence of aryl substituents on the potency and selectivity of enzyme inhibition. Compared to previously reported tacrine derivatives, the newly synthesized analogs exhibited superior inhibitory profiles, indicating their potential as lead compounds for further development in AD therapeutics.

Keywords

Acetylcholinesterase (AChE) / Aminobenzonitrile / Aryl / Butylcholinesterase (BChE) / Structure-activity relationship (SAR) / Tacrine

Cite this article

Download citation ▾
Fevzi Topal, Salih Ökten, Büşra Albayrak Misir, Ümit Muhammet Koçyiğit, Yavuz Derın, Vildan Enısoğlu Atalay, Ahmet Tutar, Meryem Topal. Novel Approach to Synthesis of Diaryl Tacrine Derivatives and Evaluation of Their Inhibitory Effects on Cholinesterase Enzymes. Chemical Research in Chinese Universities, 2026, 42(3): 983-991 DOI:10.1007/s40242-026-6048-6

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Tang J, Li J, Zhang L, Ma S, Shi D, Zhang Q, Yang L, Wang X, Liu X, Liu C. J. Heterocyclic. Chem., 2012, 49: 533

[2]

Shutske G M, Pierrat F A, Kapples K J, Cornfeldt M L, Szewczak M R, Huger F P, Bores G M, Haroutunian V, Davis K L. J. Med. Chem., 1989, 32: 1805

[3]

Ekiz M, Tutar A, Ökten S. Tetrahedron., 2016, 72: 5323

[4]

Yilmaz R F, Derin Y, Misir B A, Atalay V E, Tutar Ö F F, Ökten S, Tutar A. J. Mol. Struct., 2023, 1291: 135962

[5]

Arslan B S, Derin Y, Mısır B A, Kaya S, Şişman İ, Tutar A, Nebioğlu M. J. Mol. Struc. T., 2022, 1267: 133608

[6]

Arslan B S, Arkan B, Gezgin M, Derin Y, Avcı D, Tutar A, Nebioğlu M, Şişman İ. J. Photochem. Photobiol. A: Chem., 2021, 404: 112936

[7]

Derin Y, Arslan B S, Mısır B A, Şişman İ, Nebioğlu M, Tutar A. Chem. Heterocycl. Compd., 2020, 56: 1542

[8]

Taş S, Döndaş H A, Yaktubay Döndaş N, Poyraz S, Tok T T, Demiray G A, Belveren S, İnce T, Demir Y, Yılmaz M B, Pask C M. Future Med. Chem., 2025, 17: 2361

[9]

Aydin B O, Anil D A, Demir Y, Alagoz M A. Mol. Divers., 2024, 28: 3739

[10]

Mısır B A, Derin Y, Ökten S, Aydın A, Koçyiğit ÜM, Şahin H, Tutar A. J. Biochem. Mol. Toxicol., 2024, 38: e23706

[11]

Recanatini M, Cavalli A, Belluti F, Piazzi L, Rampa A, Bisi A, Gobbi S, Valenti P, Andrisano V, Bartolini M. J. Med. Chem., 2000, 43: 2007

[12]

Peçanha E P, Fraga C A, Barreiro E J, Braga M F, Pereira E F, Albuquerque E X. J. Braz. Chem. Soc., 2001, 12: 408

[13]

Kasapoğlu Ö, Çakici A, Sağlamtaş R, Salama M, Harb A, Sarıcı B, Demir Y. ChemistrySelect, 2026, 11: e04774

[14]

Eghtedari M, Sarrafi Y, Nadri H, Mahdavi M, Moradi A, Moghadam F H, Emami S, Firoozpour L, Asadipour A, Sabzevari O. E. J. M. Chem., 2017, 128: 237

[15]

Gök Y, Demir Y, Haroon M, Sajid Z, Tezcan B, Aktaş A, Demirci Ö, Gülçin İ, İçen Taşkın I, Gürbüz S. Polyhedron., 2025, 285: 117931

[16]

Ökten S, Ekiz M, Koçyiğit ÜM, Tutar A, Çelik İ, Akkurt M, Gökalp F, Taslimi P, Gülçin İ. J. Mol. Struct., 2019, 1175: 906

[17]

Ökten S, Ekiz M, Tutar A, Butun B, Kocyigit U M, Topcu G, Gulcin I. Indian J. Pharm. Educ. Res., 2019, 53: 268

[18]

Ökten S, Aydın A, Tutar A. S. Univ. J. Sci., 2019, 23: 824

[19]

Bulut M, Ökten S, Özcan E, Eren T. Lett. Drug. Des. Discov., 2024, 21: 101

[20]

Topal F. Int. J. Food Prop., 2019, 22: 583

[21]

Topal M. Int. J. Food Prop., 2019, 22: 1527

[22]

İnan Ergün A, Topal M. ChemistrySelect., 2023, 8: e202302751

[23]

Göçer H, Topal F, Topal M, Küçük M, Teke D, Gülçin I, Alwasel S H, Supuran C T. J. Enzyme Inhib. Med. Chem., 2016, 31: 441

[24]

Demir Y, Şenol H, Uluçay O, Ateşoğlu Ş, Tokalı F S. Comput. Biol. Chem., 2025, 120: 108683

[25]

Topal F, Yılmaz F, Topal M, Menevşeoğlu A. TURJAF, 2025, 13: 204

[26]

Demir Y, Ceylan H, Yeşilkent E N, Kizir D, Karaman M, Türkeş C, Beydemir Ş. Comput. Biol. Chem., 2025, 120: 108654

[27]

Kuzu B, Alagoz M A, Demir Y, Gulcin I, Burmaoglu S, Algul O. Mol. Divers., 2025, 29: 671

[28]

Orhan I E, Tosun F, Skalicka-Woźniak K. J. Serb. Chem. Soc., 2016, 81: 357

[29]

Gezegen H, Özbek O, Topal M, Şahin H, Koçyiğit ÜM. Biotechnol. Appl. Biochem., 2025, 73: 14

[30]

Kuzu B, Demir Y. Chem. Pap., 2025, 79: 2005

[31]

Shirisha T, Majhi S, Divakar K, Kashinath D. Org. Biomol. Chem., 2024, 22: 790

[32]

Topal F. J. Biochem. Mol. Toxicol., 2019, 33: e22385

[33]

Ashleigh T, Swerdlow R H, Beal M F. Alzheimer’s Demen., 2023, 19: 333

[34]

Muğlu H, Yakan H, Erdoğan M, Topal F, Topal M, Türkeş C, Beydemir Ş. New J. Chem., 2024, 48: 10979

[35]

Erdoğan M, Onder A, Demir Y, Comert Onder F. ACS Omega, 2024, 9: 46860

[36]

Tokalı F S, Şenol H, Demir Y, Uluçay O, Ameen M, Shafiq Z. RSC Advances, 2025, 15: 50186

[37]

Barta C, Sasvari-Szekely M, Devai A, Kovacs E, Staub M, Enyedi P. Mol. Genet. Metab., 2001, 74: 484

[38]

Behl T, Kaur I, Sehgal A, Singh S, Sharma N, Gupta S, Albratty M, Najmi A, Alhazmi H A, Bungau S. Ageing Res. Rev., 2023, 83: 101787

[39]

Bhatia V, Sharma S. J. Neurol. Sci., 2021, 421: 117253

[40]

Remya C, Dileep K V, Reddy E K, Mantosh K, Lakshmi K, Jacob R S, Sajithf A M, Variyar E J, Anwar S, Zhang K Y J, Sadasivan C, Omkumar R V. Comput. Struct. Biotechnol. J., 2021, 19: 4517

[41]

Liu W, Wu L, Li D, Huang Y, Liu M, Liu W, Tian C, Liu X, Jiang X, Hu X, Gao X, Xu Z, Lu H, Zhao Q. Bioorg. Chem., 2022, 126: 105875

[42]

Reddy E K, Remya C, Mantosh K, Sajith A M, Omkumar R V, Sadasivan C, Anwar S. Eur. J. Med. Chem., 2017, 139: 367

[43]

Kuzu B, Demir Y. Arch. Biochem. Biophys., 2025, 771: 110504

[44]

Derabli C, Boualia I, Abdelwahab A B, Boulcina R, Bensouici C, Kirsch G, Debache A. Bioorg. Med. Chem. Lett., 2018, 28: 2481

RIGHTS & PERMISSIONS

Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH

PDF

37

Accesses

0

Citation

Detail

Sections
Recommended

/